UCB/€UCB
1D1W1MYTD1Y5YMAX
Capital at risk
About UCB
UCB SA, founded in 1928, is a global biopharmaceutical company headquartered in Brussels, Belgium. The company specializes in the research, development, and commercialization of innovative therapies primarily for the treatment of neurological and immunological disorders. Operating in the healthcare sector, UCB is dedicated to advancing science and addressing unmet medical needs for patients worldwide.
- Ticker
- €UCB
- Sector
- Health
- Primary listing
- BSE
- Employees
- 9,000
- Headquarters
- Brussels, Belgium
- Website
- www.ucb.com
UCB Metrics
BasicAdvanced
€38B
17.73
€11.32
0.18
€1.02
0.51%
Price and volume
Market cap
€38B
Beta
0.18
52-week high
€288.90
52-week low
€191.50
Average daily volume
227K
Dividend rate
€1.02
Financial strength
Current ratio
1.203
Quick ratio
0.724
Long term debt to equity
28.926
Total debt to equity
30.788
Dividend payout ratio (TTM)
12.58%
Interest coverage (TTM)
32.33%
Profitability
EBITDA (TTM)
3,342
Gross margin (TTM)
76.22%
Net profit margin (TTM)
25.74%
Operating margin (TTM)
31.86%
Effective tax rate (TTM)
13.38%
Revenue per employee (TTM)
€950,000
Management effectiveness
Return on assets (TTM)
8.98%
Return on equity (TTM)
20.57%
Valuation
Price to earnings (TTM)
17.728
Price to revenue (TTM)
4.483
Price to book
3.3
Price to tangible book (TTM)
85.27
Price to free cash flow (TTM)
29.74
Free cash flow yield (TTM)
3.36%
Free cash flow per share (TTM)
6.748
Dividend yield (TTM)
0.51%
Forward dividend yield
0.51%
Growth
Revenue change (TTM)
24.47%
Earnings per share change (TTM)
64.86%
3-year revenue growth (CAGR)
18.59%
10-year revenue growth (CAGR)
7.98%
3-year earnings per share growth (CAGR)
88.56%
10-year earnings per share growth (CAGR)
12.62%
3-year dividend per share growth (CAGR)
2.92%
10-year dividend per share growth (CAGR)
2.80%
What the Analysts think about UCB
Analyst ratings (Buy, Hold, Sell) for UCB stock.
Analyst projections of the future price of UCB stock.
UCB Financial Performance
Revenues and expenses
UCB Earnings Performance
Company profitability
Upcoming events
No upcoming events
Funds containing UCB
AllEURGBPUSD
Fund name | Fund size | €UCB weighting |
|---|---|---|
iShares MSCI Europe Health Care Sector€ESIH | €863M | 1.83% |
iShares MSCI Europe Health Care Sector£ESIH | £741M | 1.83% |
iShares STOXX Europe 600 Health Care€EXV4 | €687M | 1.59% |
iShares Healthcare Innovation$HEAL | $1.4B | 1.26% |
iShares Healthcare Innovation€2B78 | €1.2B | 1.26% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.